TAK-652, a novel CCR5 inhibitor, has favourable drug interactions with other antiretrovirals in vitro.Cécile L Tremblay,Françoise Giguel,Ting-Chao Chou,Huajin Dong,Katsunori Takashima,Martin S HirschANTIVIRAL THERAPY(2005)引用 38|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要